• 1
    Szajewska H, Hoekstra JH, Sandhu B, et al. Management of acute gastroenteritis in Europe and the impact of the new recommendations: a multicenter study. J Pediatr Gastroenterol Nutr 2000; 30: 5227.
  • 2
    Guarner F, Schaafsma GJ. Probiotics. Int J Food Microbiol 1998; 39: 2378.
  • 3
    Szajewska H, Mrukowicz J. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children:a systematic review of published randomized, double-blind, placebo controlled trials. J Pediatr Gastroenterol Nutr 2001; 33: S1725.
  • 4
    Van Niel C, Feudtner C, Garrison MM, Christakis DA. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 2002; 109: 67884.
  • 5
    Huang JS, Bousvaros A, Lee JW, et al. Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci 2002; 47: 262534.
  • 6
    Allen SJ, Okoko B, Martinez E, et al. Probiotics for treating infectious diarrhoea. The Cochrane Database of Systematic Reviews. Issue 4, 2003.
  • 7
    Bernardeau M, Vernoux JP, Gueguen M. Safety and efficacy of probiotic lactobacilli in promoting growth in post-weaning Swiss mice. Int J Food Microbiol 2002; 77: 1927.
  • 8
    Rachmilewitz D, Karmeli F, Takabayashi K, et al. Amelioration of experimental colitis by probiotics is due to the immunostimulatory effect of its DNA. Gastroenterology 2002; 122: T1004 (Abstract) .
  • 9
    Madsen K, Jijon H, Yeung H, et al. DNA from probiotic bacteria exerts anti-inflammatory actions on epithelial cells by inhibition of NFκB. Gastroenterology 2002; 122: 546 (Abstract).
  • 10
    Sutton AJ, Duval SJ, Tweedie RL, Abrams KR, Jones DR. Empirical assessment of effect of publication bias on meta-analyses. Br Med J 2000; 320: 15747.
  • 11
    Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997; 315: 62934.
  • 12
    Costa-Ribeiro H, Ribeiro TC, Mattos AP, et al. Limitations of probiotic therapy in acute, severe dehydrating diarrhea. J Pediatr Gastroenterol Nutr 2003; 36: 11215.
  • 13
    Guandalini S, Pensabene L, Zikri MA, et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr 2000; 30: 5460.
  • 14
    Guarino A, Canani RB, Spagnuolo MI, et al. Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea. J Pediatr Gastroenterol Nutr 1997; 25: 51619.
  • 15
    Isolauri E, Kaila M, Mykkanen H, et al. Oral bacteriotherapy for viral gastroenteritis. Dig Dis Sci 1994; 39: 2595600.
  • 16
    Raza S, Graham SM, Allen SJ, et al. Lactobacillus GG promotes recovery from acute nonbloody diarrhea in Pakistan. Pediatr Infect Dis J 1995; 14: 10711.
  • 17
    Salazar-Lindo E, Miranda-Langschwager P, Campos-Sanchez M, et al. Lactobacillus casei strain GG in the treatment of infants with acute watery diarrhea: a randomized, double-blind, placebo controlled clinical trial [ISRCTN67363048]. BMC Pediatr 2004; 4: 18.
  • 18
    Shornikova AV, Isolauri E, Burkanova L, et al. A trial in the Karelian Republic of oral rehydration and Lactobacillus GG for treatment of acute diarrhoea. Acta Paediatr 1997; 86: 4605.
  • 19
    Jasinski C, Tanzi MN, Schelotto F, et al. Efficacy of Lactobacillus GG in oral rehydration solution. Pediátrica 2002; 22: 23143 (In Spanish).
  • 20
    Kaila M, Isolauri E, Saxelin M, et al. Viable versus inactivated lactobacillus strain GG in acute rotavirus diarrhoea. Arch Dis Child 1995; 72: 513.
  • 21
    Pant AR, Graham SM, Allen SJ, et al. Lactobacillus GG and acute diarrhoea in young children in the tropics. J Trop Pediatr 1996; 42: 1625.
  • 22
    Kaila M, Isolauri E, Soppi E, et al. Ehancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res 1992; 32: 1414.
  • 23
    Isolauri E, Juntunen M, Rautanen T, et al. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 1991; 88: 907.
  • 24
    Majamaa H, Isolauri E, Saxelin M, et al. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 1995; 20: 3338.
  • 25
    Rautanen T, Isolauri E, Salo E, et al. Management of acute diarrhoea with low osmolarity oral rehydration solutions and Lactobacillus strain GG. Arch Dis Child 1998; 79: 15760.
  • 26
    World Health Organization. The Rational Use of Drugs in the Management of Acute Diarrhoea in Children. Geneva, Switzerland: World Health Organization, 1990.
  • 27
    Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354: 1122.
  • 28
    Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354: 2333.
  • 29
    De Groote MA, Frank DN, Dowell E, et al. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J 2005; 24: 27880.
  • 30
    Land MH, Rouster-Stevens K, Woods CR, et al. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005; 115: 17881.